Abstract

Vaginal Candidacies or vaginal candidial infection is one of the most common infections in reproductive age and older age woman. It is usually managed by first line treatment of azoles and other antifungal antibiotics through oral, tropical and intra-vaginal preparations. Followed by if recurrence observed, intravenous preparation also administrated. During the past decades, the incidence of vaginal candidiasis and recurrent vaginal Candidiasis was frequently occurred due to poor/ mis-diagnosis, development of drug resistance, infection by non albicans species, phenotypic and genetic adaptation towards the drug Candidate. Even though, there are enormous new antifungal antibiotics was introduced but the incidence of drug resistance was more concern. So in order to overcome this circumstance the researchers are tend to make a new Candida to prevent the Candida infection. In this review we are trying to achieve the importance Candida vaccine thus should provide a better option for candidiasis.